FDA says Sinopharm EUA application lacks documents

The Food and Drug Administration (FDA) will wait for Sinopharm to submit its required documents before evaluating and granting the emergency use authorization (EUA).

In a public briefing, FDA Director General Eric Domingo confirmed that a local pharmaceutical company distributor has applied for an EUA on Monday. However, it is still lacking the needed documents for an evaluation. The company only submitted the Phase 1 trial and letter of intent.

FDA Dir. Gen. Domingo assured that the process for the evaluation will be fast provided that all necessary documents are given to them. The process will be quicker if an EUA from a stringent regulatory authority has been given to the company. – Report from Mark Fetalco

Popular

PBBM pushes for MSME empowerment, digital trade at APEC

By Darryl John Esguerra | Philippine News Agency President Ferdinand R. Marcos Jr. urged Asia-Pacific economies to empower micro, small, and medium enterprises (MSMEs) and...

‘Tumba’: Honoring the dead through the lens of Paoay

By Brian Campued Every All Saints’ Day (Nov. 1) in the small town of Paoay in Ilocos Norte, residents not only visit the graves of...

PBBM to OFWs: Gov’t working to reach you wherever you are in the world

By Darryl John Esguerra | Philippine News Agency President Ferdinand R. Marcos Jr. on Thursday assured overseas Filipinos that his administration is working to make...

First Couple graces ‘Thrilla in Manila’ 2

By Brian Campued Underscoring the administration’s commitment to supporting sports development and inspiring the next generation of Filipino athletes, President Ferdinand R. Marcos Jr. and...